Generation and optimization of a chimeric antigen receptor against human CD22: A new immunotherapeutic agent for adoptive immunotherapy

被引：0
|
作者：
Haso, Waleed [1 ]
Lee, Daniel [1 ]
Morgan, Richard [1 ]
Pastan, Ira [1 ]
Mackall, Crystal [1 ]
Orentas, Rimas J. [1 ]
机构：
[1] NIH, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3504
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficient chimeric antigen receptor targeting of a central epitope of CD22
    Casey, Nicholas Paul
    Klee, Clara Helena
    Fane, Anne
    Caulier, Benjamin
    Graczyk-Jarzynka, Agnieszka
    Krawczyk, Marta
    Fidyt, Klaudyna
    Josefsson, Sarah E.
    Koeksal, Hakan
    Dillard, Pierre
    Patkowska, Elzbieta
    Firczuk, Malgorzata
    Smeland, Erlend B.
    Winiarska, Magdalena
    Myklebust, June H.
    Inderberg, Else Marit
    Waelchli, Sebastien
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (07)
  • [2] Modulation of CD22 Antigen Density Improves Efficacy of CD22 Chimeric Antigen Receptor (CAR) T Cells Against CD22lo B-Lineage Leukemia and Lymphoma
    Ramakrishna, Sneha
    Nguyen, Sang M.
    Qin, Haiying
    Highfill, Steven L.
    Kraft, Ira
    Shern, John
    Walsh, Zachary
    Dimitrov, Dimiter
    Fry, Terry J.
    BLOOD, 2017, 130
  • [3] Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22
    Qin, Haiying
    Haso, Waleed
    Sang Minh Nguyen
    Fry, Terry J.
    BLOOD, 2015, 126 (23)
  • [4] Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
    McComb, Scott
    Arbabi-Ghahroudi, Mehdi
    Hay, Kevin A.
    Keller, Brian A.
    Faulkes, Sharlene
    Rutherford, Michael
    Nguyen, Tina
    Shepherd, Alex
    Wu, Cunle
    Marcil, Anne
    Aubry, Annie
    Hussack, Greg
    Pinto, Devanand M.
    Ryan, Shannon
    Raphael, Shalini
    van Faassen, Henk
    Zafer, Ahmed
    Zhu, Qin
    Maclean, Susanne
    Chattopadhyay, Anindita
    Gurnani, Komal
    Gilbert, Renald
    Gadoury, Christine
    Iqbal, Umar
    Fatehi, Dorothy
    Jezierski, Anna
    Huang, Jez
    Pon, Robert A.
    Sigrist, Mhairi
    Holt, Robert A.
    Nelson, Brad H.
    Atkins, Harold
    Kekre, Natasha
    Yung, Eric
    Webb, John
    Nielsen, Julie S.
    Weeratna, Risini D.
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (01):
  • [5] CD19/CD22 bispecific chimeric antigen receptor-NK-92 cells are developed and evaluated
    Kim, Hyori
    Han, Mina
    Kim, Minsong
    Kim, Hyeri
    Im, Ho Joon
    Kim, Nayoung
    Koh, Kyung-Nam
    ONCOLOGY LETTERS, 2023, 25 (06)
  • [6] Adoptive T cell immunotherapy using chimeric antigen receptor against a novel cancer target Axl
    Intisar, Ejaj
    Walsh, Anthony
    Weinberg, Benjamin
    Chakravarti, Deboki
    Wong, Wilson
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [7] Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23
    Raj, D.
    Peggs, K.
    Pule, M.
    Linch, D.
    Davies, M.
    Nathwani, A.
    HUMAN GENE THERAPY, 2011, 22 (10) : A120 - A121
  • [8] Adoptive T-cell immunotherapy using chimeric antigen receptor against a novel cancer target Axl
    Intisar, E.
    Walsh, A.
    Weinberg, B.
    Chakravarti, D.
    Wong, W.
    IMMUNOLOGY, 2014, 143 : 148 - 148
  • [9] Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells
    Allegra, Alessandro
    Innao, Vanessa
    Gerace, Demetrio
    Vaddinelli, Doriana
    Musolino, Caterina
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 62 : 49 - 63
  • [10] CD22 IS PART OF THE HUMAN SLGM B-CELL ANTIGEN RECEPTOR SIGNALING COMPLEX
    LEPRINCE, C
    DRAVES, KA
    LEDBETTER, JA
    GEAHLEN, RA
    CLARK, EA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 254 - 254
12345